Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Editorial comment on Evolution, controversies and the future of prostate cancer grading.

Tsuzuki T.

Pathol Int. 2019 Feb;69(2):67. doi: 10.1111/pin.12773. Epub 2019 Feb 9. No abstract available.

PMID:
30738006
2.

Evolution, controversies and the future of prostate cancer grading.

Egevad L, Delahunt B, Yaxley J, Samaratunga H.

Pathol Int. 2019 Feb;69(2):55-66. doi: 10.1111/pin.12761. Epub 2019 Jan 29. Review.

PMID:
30694570
3.

Editorial comment.

Thomas C, Thüroff JW.

Urology. 2015 Apr;85(4):746. doi: 10.1016/j.urology.2014.10.061. Epub 2015 Feb 21. No abstract available.

PMID:
25709047
4.

Editorial Comment to Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?

Suzuki M.

Int J Urol. 2012 Feb;19(2):167-8. doi: 10.1111/j.1442-2042.2011.02910.x. Epub 2011 Nov 17. No abstract available.

5.

Editorial comment.

Labanaris AP.

J Urol. 2013 Mar;189(3):866. doi: 10.1016/j.juro.2012.10.133. Epub 2012 Dec 20. No abstract available.

PMID:
23261235
6.

Comment on 'Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome'.

Dell'Oglio P, Stabile A, Gandaglia G, Briganti A.

Br J Cancer. 2017 Jan;116(3):e3. doi: 10.1038/bjc.2016.346. Epub 2016 Oct 25. No abstract available.

7.

Reply to 'Comment on "Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome"'.

Berney DM.

Br J Cancer. 2017 Jan;116(3):e4. doi: 10.1038/bjc.2016.347. Epub 2016 Oct 25. No abstract available.

8.

Re: Comment on Egevad et al., 'Utility of Pathology Imagebase for standardisation of prostate cancer grading'.

Egevad L, Samaratunga H, Delahunt B.

Histopathology. 2018 Aug;73(2):361-362. doi: 10.1111/his.13637. Epub 2018 May 30. No abstract available.

PMID:
29672898
9.

Editorial Comment.

Punnen S.

J Urol. 2019 Jan;201(1):83. doi: 10.1097/01.ju.0000550159.26431.46. No abstract available.

PMID:
30577394
10.

Editorial Comment.

Perlis N.

J Urol. 2019 Jan;201(1):82. doi: 10.1097/01.ju.0000550126.92849.00. No abstract available.

PMID:
30577393
11.

Editorial Comment.

Egevad L.

J Urol. 2017 Jan;197(1):81-82. doi: 10.1016/j.juro.2016.07.102. Epub 2016 Oct 4. No abstract available.

PMID:
27717692
12.

Editorial Comment.

Iczkowski KA.

J Urol. 2017 Jan;197(1):82. doi: 10.1016/j.juro.2016.07.103. Epub 2016 Oct 4. No abstract available.

PMID:
27717689
13.

Editorial Comment.

Tollefson MK.

J Urol. 2017 Jan;197(1):82. doi: 10.1016/j.juro.2016.07.104. Epub 2016 Oct 4. No abstract available.

PMID:
27717688
14.

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee.

Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Review.

PMID:
26492179
15.

Editorial Comment.

Eggener SE.

J Urol. 2016 Dec;196(6):1668-1669. doi: 10.1016/j.juro.2016.06.103. Epub 2016 Sep 6. No abstract available.

PMID:
27613117
16.

Prostate cancer grading: recent developments and future directions.

Delahunt B, Egevad L, Grignon DJ, Srigley JR, Samaratunga H.

BJU Int. 2016 Apr;117 Suppl 4:7-8. doi: 10.1111/bju.13467. No abstract available.

17.

SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.

Pierconti F, Martini M, Cenci T, Petrone GL, Ricci R, Sacco E, Bassi PF, Larocca LM.

Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.

PMID:
28144985
18.

Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.

Delahunt B, Grignon DJ, Samaratunga H, Srigley JR, Leite KR, Kristiansen G, Evans AJ, Kench JG, Egevad L.

Arch Pathol Lab Med. 2017 Feb;141(2):182-183. doi: 10.5858/arpa.2016-0300-LE. No abstract available.

PMID:
28134585
19.

Editorial comment.

Jones JS.

J Urol. 2014 Jun;191(6):1754. doi: 10.1016/j.juro.2013.12.064. Epub 2014 Mar 17. No abstract available.

PMID:
24651026
20.

Editorial comment.

Hadaschik BA, Kuru TH.

J Urol. 2014 Jun;191(6):1754. doi: 10.1016/j.juro.2013.12.063. Epub 2014 Mar 17. No abstract available.

PMID:
24651025

Supplemental Content

Support Center